ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Impact of Donor Genotype on Recipient Tacrolimus Pharmacokinetics: The Liver Matters.

S. Tremblay,1 T. Fukuda,2 T. Mizuno,2 E. Woodle,1 B. Abu Jawdeh,1 A. Govil,1 U. Christians,3 J. Klawitter,3 A. Vinks,2 R. Alloway.1

1U of Cinicnnati, Cincinnati
2Cincinnati Children's, Cincinnati
3iC42 Clinical Research, Colorado

Meeting: 2017 American Transplant Congress

Abstract number: D205

Keywords: Genomics, Immunosuppression, Pharmacokinetics, Risk factors

Session Information

Session Name: Poster Session D: Liver: Immunosuppression and Rejection

Session Type: Poster Session

Date: Tuesday, May 2, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Tacrolimus (Tac) is a cornerstone immunosuppressant metabolized in the gut and liver, resulting in high intra/inter patient pharmacokinetic (PK) variability. Recipient genotype (RG) impacts tac PK. CPIC guidelines recommend genotyping recipients to tailor tac dosing. Few studies have evaluated the impact of donor genotype (DG) following liver and small bowel transplantation, where DG and RG may differ.

Methods: 24 liver recipients (LT) and 18 kidney recipients (KT) in a prospective tac PK study had donor tissue genotyped for CYP3A5, CYP3A4 (*1B and *22), ABCB1, POR*28 following consent and authorization . Tac and metabolite PK parameters were obtained from 12-hour sampling analyzed via LC-MS/MS and derived using NONMEM. One-way ANOVA was used to evaluate genotype effect on apparent clearance (CL/F) and the area under the curve (AUC) ratios of tac to its main metabolite 13-O-desmethyltacrolimus (13-ODMT).

Results: PK parameters were well characterized; results for CYP3A5 variants are presented. Tac CL/F was not affected by DG in KT but recipient *1 variants significantly increased CL/F. Conversely, liver donor *1 variant had a higher CL/F whereas recipient did not (Fig 1). For 13-ODMT, kidney donor CYP3A5*1 had no impact on the 13-ODMT to tac AUC ratio whereas liver donor *1 increased it (Fig 2).Conclusion: DG impacts tac and 13-ODMT PK in LT but not in KT. Kidney RG influenced CL/F, liver RG did not. CPIC guidelines recommend genotyping recipients for CYP3A5 to guide tac dosing and that in LT, DG may need to be considered. Our results support this statement. Prospective studies should evaluate the impact of recipient-DG on PK, clinical outcomes, biomarkers and relative importance of intestinal vs hepatic metabolism.

CITATION INFORMATION: Tremblay S, Fukuda T, Mizuno T, Woodle E, Abu Jawdeh B, Govil A, Christians U, Klawitter J, Vinks A, Alloway R. Impact of Donor Genotype on Recipient Tacrolimus Pharmacokinetics: The Liver Matters. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Tremblay S, Fukuda T, Mizuno T, Woodle E, Jawdeh BAbu, Govil A, Christians U, Klawitter J, Vinks A, Alloway R. Impact of Donor Genotype on Recipient Tacrolimus Pharmacokinetics: The Liver Matters. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-donor-genotype-on-recipient-tacrolimus-pharmacokinetics-the-liver-matters/. Accessed May 12, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences